You are not logged in. (Sign In)
PI: Csernansky
Summary:
To determine whether drugs currently used to treat Alzheimer disease alter the underlying disease process, as assessed using markers of brain structure and cognition in dementia patients and markers of amyloid deposition and neurodegeneration in APP-transgenic mice.
Papers: